U respira\u010dn\u00edch infekc\u00ed prov\u00e1d\u00edme antigenn\u00ed testy k vylou\u010den\u00ed mo\u017en\u00e9 Covid-19 infekce, podle pot\u00ed\u017e\u00ed pacienta prov\u00e1d\u00edme i test na ch\u0159ipku.<\/p>\n\n\n\n
Pokud by byl potvrzena Covid-19 infekce, terapie je symtomatick\u00e1 v\u010detn\u011b adekv\u00e1tn\u00ed vitam\u00ednoterapie a u rizikov\u00fdch pacient\u016f mo\u017en\u00e9 nasadit dle indika\u010dn\u00edch krit\u00e9ri\u00ed antivirotikum Lagevrio \u010di Paxlovid.<\/p>\n\n\n\n
V p\u0159\u00edpad\u011b potvrzen\u00ed ch\u0159ipky je tak\u00e9 terapie symtomatick\u00e1 v\u010detn\u011b adekv\u00e1tn\u00ed vitam\u00ednoterapie, antivirotikum Tamiflu lze napsat u rizikov\u00fdch pacient\u016f dle indika\u010dn\u00edho seznamu.<\/p>\n\n\n\n
V\u011bt\u0161ina respira\u010dn\u00edch infekc\u00ed a vybran\u00e9 bakteri\u00e1n\u00ed jsou SAMO\u00daZDRAVN\u00c9, obavy z tzv. „bakteri\u00e1ln\u00ed <\/strong>superinfekce“ jsou p\u0159ece\u0148ovan\u00e9.<\/p>\n\n\n\n Odli\u0161en\u00ed virov\u00e9 od bakteri\u00e1ln\u00ed infekce je relativn\u011b obt\u00ed\u017en\u00e9, ani CRP NEN\u00cd DOSTAE\u010cN\u011a spolehliv\u00fd marker, b\u00fdv\u00e1 \u010cASTO ZV\u00dd\u0160EN\u00c9 i u VIROV\u00ddCH infekc\u00ed- ch\u0159ipka, enteroviry, Covid- 19.<\/strong> Proto je vhodn\u00e9 se n\u011bkdy vr\u00e1tit i ke klasick\u00e9mu krevn\u00edmu obrazu a t\u0159eba i sedimentaci.<\/p>\n\n\n\n Virov\u00e9 infekce obvykle vyvol\u00e1vaj\u00ed v\u00edceet\u00e1\u017eov\u00e9 \u010di v\u00edceslizni\u010dn\u00ed posti\u017een\u00ed- nap\u0159.kombinace r\u00fdma, ka\u0161el, bolest v krku, zat\u00edmco bakteri\u00e1ln\u00ed infekce b\u00fdvaj\u00ed obvykle lokalizovan\u00e9, nap\u0159. sp\u00e1lov\u00e1 ang\u00edna, u kter\u00e9 je l\u00e9kem volby antibiotikum PNC \u0159ady.<\/p>\n\n\n\n Z\u00e1kladn\u00ed princip antibiotick\u00e9 terapie u akutn\u00edch respira\u010dn\u00edch infekc\u00ed je vylou\u010dit potenci\u00e1ln\u011b z\u00e1va\u017en\u00e9 infekce.<\/p>\n\n\n\n Nar\u016fstaj\u00edc\u00ed rezistence bakteri\u00ed na antibiotika p\u0159edstavuje z\u00e1va\u017en\u00fd probl\u00e9m pro sou\u010dasnou medic\u00ednu!<\/p>\n\n\n\n nap\u0159. 486 je odhadovan\u00fd po\u010det \u00famrt\u00ed na infekce vyvolan\u00e9 multirezistentn\u00edmi bakteriemi (\u010cR 2015)<\/p>\n\n\n\n ANTIBIOTIKA<\/strong> jsou rozd\u011blena na tzv:<\/p>\n\n\n\n ACCESS- jsou to relativn\u011b m\u00e1lo rizikov\u00e1 antibiotika, kter\u00e1 maj\u00ed n\u00edzk\u00fd potenci\u00e1l pro indukci rezistence, tzv. ekologick\u00e1 ATB- penicilin, flukloxacilin, amoxillin, amoxicillin\/klavulon\u00e1t, cefadroxil, klindamycin, doxycyklin, kotrimoxazol, pivmeciliam, nitrofurantoin, metronidazol<\/strong><\/p>\n\n\n\n WATCH- pod\u00e1n\u00ed t\u011bchto antibiotik by m\u011blo b\u00fdt v\u00e1zan\u00e9 na specifick\u00e9 a limitovan\u00e9 indikace-<\/p>\n\n\n\n azitromycin, klaritromycin, spiramycin, ciprofloxacin, ofloxacin, cefuroxim, cepfrozil, rifampicin a fosfomycin<\/p>\n\n\n\n RESERVE- rozhoduje ATB centrum<\/p>\n\n\n\n zdroj: BULLETIN 3\/2022<\/p>\n","protected":false},"excerpt":{"rendered":" U respira\u010dn\u00edch infekc\u00ed prov\u00e1d\u00edme antigenn\u00ed testy k vylou\u010den\u00ed mo\u017en\u00e9 Covid-19 infekce, podle pot\u00ed\u017e\u00ed pacienta prov\u00e1d\u00edme i test na ch\u0159ipku. Pokud by byl potvrzena Covid-19 infekce, terapie je symtomatick\u00e1 v\u010detn\u011b adekv\u00e1tn\u00ed vitam\u00ednoterapie a u rizikov\u00fdch pacient\u016f mo\u017en\u00e9 nasadit dle indika\u010dn\u00edch krit\u00e9ri\u00ed antivirotikum Lagevrio \u010di Paxlovid. V p\u0159\u00edpad\u011b potvrzen\u00ed ch\u0159ipky je tak\u00e9 terapie symtomatick\u00e1 v\u010detn\u011b adekv\u00e1tn\u00ed vitam\u00ednoterapie, […]<\/p>\n","protected":false},"author":591,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"wds_primary_category":0,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-880","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/docsites.cgmlife.com\/puvl\/wp-json\/wp\/v2\/posts\/880","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/docsites.cgmlife.com\/puvl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/docsites.cgmlife.com\/puvl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/docsites.cgmlife.com\/puvl\/wp-json\/wp\/v2\/users\/591"}],"replies":[{"embeddable":true,"href":"https:\/\/docsites.cgmlife.com\/puvl\/wp-json\/wp\/v2\/comments?post=880"}],"version-history":[{"count":1,"href":"https:\/\/docsites.cgmlife.com\/puvl\/wp-json\/wp\/v2\/posts\/880\/revisions"}],"predecessor-version":[{"id":881,"href":"https:\/\/docsites.cgmlife.com\/puvl\/wp-json\/wp\/v2\/posts\/880\/revisions\/881"}],"wp:attachment":[{"href":"https:\/\/docsites.cgmlife.com\/puvl\/wp-json\/wp\/v2\/media?parent=880"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/docsites.cgmlife.com\/puvl\/wp-json\/wp\/v2\/categories?post=880"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/docsites.cgmlife.com\/puvl\/wp-json\/wp\/v2\/tags?post=880"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}